Summary: Aidoc is working with NVIDIA to develop the BRIDGE guideline, planned for release in early 2025, which will offer a framework to improve AI adoption in healthcare by addressing challenges related to fragmentation, inefficiencies, and scalability, with a focus on validation, interoperability, and monitoring.
Key Takeaways
- Aidoc and NVIDIA are collaborating to develop BRIDGE, a guideline aimed at improving AI adoption in healthcare by addressing fragmentation, inefficiencies, and scalability challenges.
- BRIDGE will provide a framework for validating AI tools, supporting interoperability between vendors, and ensuring scalable deployment across hospital systems.
- The guideline will align with existing frameworks like MONAI to build on standardization and scalability in medical AI, with an emphasis on continuous monitoring and real-world application.
———————————————————————————————————————————————————————————————
Clinical artificial intelligence (AI) company Aidoc is collaborating with NVIDIA to co-develop the Blueprint for Resilient Integration and Deployment of Guided Excellence (BRIDGE), a guideline aimed at improving AI adoption in healthcare.
BRIDGE, planned for release in early 2025, will provide a framework for integrating AI into clinical workflows. While more than 900 FDA-cleared AI tools exist for medical imaging, many healthcare systems continue to face fragmentation, inefficiencies, and scalability challenges. BRIDGE aims to address these issues with a neutral approach to improving AI deployment.
Improving AI Validation and Interoperability in Healthcare
The guideline will focus on validating AI tools for practical use, supporting interoperability to integrate solutions from various vendors, and providing strategies for scalable deployment across hospital systems. It will also stress the importance of continuous monitoring to maintain AI accuracy after implementation.
“AI holds the potential to revolutionize patient care, but its progress has been stalled by fragmented systems and the inability to scale effectively,” says Demetri Giannikopoulos, chief transformation officer at Aidoc. “The BRIDGE guideline will focus on breaking down these barriers, offering a powerful, evidence-based framework that health systems can rely on not just to adopt AI but to help scale it across their operations.”
Scalability for Broader AI Adoption
The BRIDGE guideline will also align with existing frameworks such as MONAI, an open-source platform co-founded by NVIDIA, which supports the development, validation, and deployment of medical AI. MONAI’s focus on standardization and scalability, along with its use in FDA-approved applications, will serve as a foundation for BRIDGE’s development.
Developed through collaboration with healthcare providers, academic partners, and industry leaders, BRIDGE will address real-world challenges in AI integration, providing healthcare organizations with a practical and adaptable framework for broader AI adoption.
